It's How Medicine Should Be®
<< Previous | New Search | Return to Search Results | Next >>

Physician Profile

-or-

call (888) 352-RUSH for help arranging an appointment

Photo Not Available

Zoe Arvanitakis, MD, MS

Specialty:
  • Neurology
Faculty Rank: Associate Professor
Medical or Graduate Education: University of Western Ontario Faculty of Medicine, Canada
Residency: University of Manitoba, Canada - Neurology
Fellowship: Mayo Clinic, Jacksonville, Fla. - Dementia
Clinical Expertise:
  • Alzheimer's disease
  • Dementia
Google Map

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

  1. Astroglial heme oxygenase-1 and the origin of corpora amylacea in aging and degenerating neural tissues.
    Song W, Zukor H, Liberman A, Kaduri S, Arvanitakis Z, Bennett DA, Schipper HM
    Exp. Neurol.
    2014 Apr
    254:78-89.
  2. Faster cognitive decline in the years prior to MR imaging is associated with smaller hippocampal volumes in cognitively healthy older persons.
    Fleischman DA, Yu L, Arfanakis K, Han SD, Barnes LL, Arvanitakis Z, Boyle PA, Bennett DA.
    Front Aging Neurosci. 2013
    2013 Jun 5
    5:21. doi: 10.3389/fnagi.2013.00021. Print 2013.
  3. Selected findings from the religious orders study and rush memory and aging project.
    Bennett DA, Wilson RS, Arvanitakis Z, Boyle PA, de Toledo-Morrell L, Schneider JA.
    J Alzheimers Dis. 2013
    2013 Jan 1
    33(0):S397-403. doi: 10.3233/JAD-2012-129007.
  4. Gray-matter macrostructure in cognitively healthy older persons: associations with age and cognition.
    Fleischman DA, Leurgans S, Arfanakis K, Arvanitakis Z, Barnes LL, Boyle PA, Han SD, Bennett DA
    Brain Struct Funct
    2013 Aug 17
  5. Antiphospholipid Antibodies, Brain Infarcts, and Cognitive and Motor Decline in Aging (ABICMA): Design of a Community-Based, Longitudinal, Clinical-Pathological Study.
    Arvanitakis Z, Brey RL, Rand JH, Schneider JA, Leurgans SE, Yu L, Buchman AS, Arfanakis K, Fleischman DA, Boyle PA, Bennett DA, Levine SR.
    Neuroepidemiology. 2012
    2012 Oct 24
    40(2):73-84. [Epub ahead of print]
  6. Overview and findings from the religious orders study.
    Bennett DA, Schneider JA, Arvanitakis Z, Wilson RS.
    Curr Alzheimer Res. 2012
    2012 Jul
    9(6):628-45.
  7. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.
    Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennett DA, Trojanowski JQ, Arnold SE.
    J Clin Invest. 2012
    2012 Apr 2
    122(4):1316-38. doi: 10.1172/JCI59903.
  8. Microinfarct pathology, dementia, and cognitive systems.
    Arvanitakis Z, Leurgans SE, Barnes LL, Bennett DA, Schneider JA.
    Stroke. 2011
    2011 Mar
    42(3):722-7. doi: 10.1161/STROKEAHA.110.595082. Epub 2011 Jan 6.
  9. Cerebral amyloid angiopathy pathology and cognitive domains in older persons.
    Arvanitakis Z, Leurgans SE, Wang Z, Wilson RS, Bennett DA, Schneider JA.
    Ann Neurol. 2011
    2011 Feb
    69(2):320-7. doi: 10.1002/ana.22112. Epub 2010 Nov 8.
  10. Clinical trial efforts in Alzheimer disease: why test statins?
    Arvanitakis Z, Knopman DS
    Neurology
    2010 Mar 23
    74(12):945-6
  11. Diabetes and cognitive systems in older black and white persons.
    Arvanitakis Z, Bennett DA, Wilson RS, Barnes LL.
    Alzheimer Dis Assoc Disord. 2010
    2010 Jan-Mar
    24(1):37-42. doi: 10.1097/WAD.0b013e3181a6bed5.
  12. Parkinsonian signs and incident falls in older persons without Parkinson's disease.
    Buracchio T, Arvanitakis Z, Leurgans S, Bennett DA.
    J Am Geriatr Soc. 2010
    2010 Jan
    58(1):205-6. doi: 10.1111/j.1532-5415.2009.02657.x. No abstract available.
  13. Update on frontotemporal dementia.
    Arvanitakis Z.
    Neurologist. 2010
    2010 Jan
    16(1):16-22. doi: 10.1097/NRL.0b013e3181b1d5c6. Review.
  14. Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase-1.
    Hascalovici JR, Vaya J, Khatib S, Holcroft CA, Zukor H, Song W, Arvanitakis Z, Bennett DA, Schipper HM.
    J Neurochem. 2009
    2009 Aug
    110(4):1241-53. doi: 10.1111/j.1471-4159.2009.06213.x. Epub 2009 Jun 9.
  15. The neuropathology of probable Alzheimer disease and mild cognitive impairment.
    Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA.
    Ann Neurol. 2009
    2009 Aug
    66(2):200-8. doi: 10.1002/ana.21706.
  16. Statins, incident Alzheimer disease, change in cognitive function, and neuropathology
    Arvanitakis Z, Schneider JA, Wilson RS, Bienias JL, Kelly JF, Evans DA, Bennett DA
    Neurology
    2008 May 6
    70(19 Pt 2):1795-802
  17. Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology
    Arvanitakis Z, Grodstein F, Bienias JL, Schneider JA, Wilson RS, Kelly JF, Evans DA, Bennett DA
    Neurology
    2008 Jun 3
    70(23):2219-25